192 related articles for article (PubMed ID: 22882693)
21. Risk factors for infection and treatment outcome of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy.
Kang CI; Chung DR; Ko KS; Peck KR; Song JH;
Ann Hematol; 2012 Jan; 91(1):115-21. PubMed ID: 21556875
[TBL] [Abstract][Full Text] [Related]
22. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.
Tumbarello M; Viale P; Viscoli C; Trecarichi EM; Tumietto F; Marchese A; Spanu T; Ambretti S; Ginocchio F; Cristini F; Losito AR; Tedeschi S; Cauda R; Bassetti M
Clin Infect Dis; 2012 Oct; 55(7):943-50. PubMed ID: 22752516
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients.
Pouch SM; Kubin CJ; Satlin MJ; Tsapepas DS; Lee JR; Dube G; Pereira MR
Transpl Infect Dis; 2015 Dec; 17(6):800-9. PubMed ID: 26341757
[TBL] [Abstract][Full Text] [Related]
24. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
Lee CI; Lee NY; Yan JJ; Lee HC; Ko NY; Chang CM; Wu CJ; Chen PL; Wang LR; Ko WC
J Microbiol Immunol Infect; 2009 Aug; 42(4):303-9. PubMed ID: 19949753
[TBL] [Abstract][Full Text] [Related]
25. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
[TBL] [Abstract][Full Text] [Related]
26. Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.
Bleumin D; Cohen MJ; Moranne O; Esnault VL; Benenson S; Paltiel O; Tzukert K; Mor-Yosef Levi I; Ben-Dov IZ; Levi R; Bloch A; Haviv YS
J Infect; 2012 Oct; 65(4):318-25. PubMed ID: 22722020
[TBL] [Abstract][Full Text] [Related]
27. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.
Falagas ME; Rafailidis PI; Kofteridis D; Virtzili S; Chelvatzoglou FC; Papaioannou V; Maraki S; Samonis G; Michalopoulos A
J Antimicrob Chemother; 2007 Nov; 60(5):1124-30. PubMed ID: 17884829
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
29. Clinical Significance of Gastrointestinal Carriage of Klebsiella Pneumoniae-Producing Extended-Spectrum Beta-Lactamases in Kidney Graft Recipients.
Wilkowski P; Gajko K; Marczak M; Hryniewiecka E; Wojtowicz M; Dobrzaniecka K; Mlynarczyk G; Paczek L; Ciszek M
Transplant Proc; 2018; 50(6):1874-1877. PubMed ID: 30056919
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors for Acquisition of Carbapenem-Resistant Klebsiella pneumoniae and Mortality Among Abdominal Solid Organ Transplant Recipients with K. pneumoniae Infections.
Wu D; Chen C; Liu T; Wan Q
Med Sci Monit; 2020 Aug; 26():e922996. PubMed ID: 32807765
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.
Borer A; Saidel-Odes L; Eskira S; Nativ R; Riesenberg K; Livshiz-Riven I; Schlaeffer F; Sherf M; Peled N
Am J Infect Control; 2012 Jun; 40(5):421-5. PubMed ID: 21906844
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.
Kritsotakis EI; Tsioutis C; Roumbelaki M; Christidou A; Gikas A
J Antimicrob Chemother; 2011 Jun; 66(6):1383-91. PubMed ID: 21454344
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of transplantation using organs from a donor infected with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae.
Ariza-Heredia EJ; Patel R; Blumberg EA; Walker RC; Lewis R; Evans J; Sankar A; Willliams MD; Rogers J; Milano C; Razonable RR
Transpl Infect Dis; 2012 Jun; 14(3):229-36. PubMed ID: 22624726
[TBL] [Abstract][Full Text] [Related]
35. Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation.
Varotti G; Dodi F; Terulla A; Santori G; Mariottini G; Bertocchi M; Marchese A; Fontana I
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28796391
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon.
Araj GF; Jaber FA
J Med Liban; 2012; 60(3):142-7. PubMed ID: 23198454
[TBL] [Abstract][Full Text] [Related]
37. Mortality due to blaKPC Klebsiella pneumoniae bacteraemia.
Fraenkel-Wandel Y; Raveh-Brawer D; Wiener-Well Y; Yinnon AM; Assous MV
J Antimicrob Chemother; 2016 Apr; 71(4):1083-7. PubMed ID: 26661396
[TBL] [Abstract][Full Text] [Related]
38. Klebsiella necrotizing soft tissue infections in liver transplant recipients: a case series.
Rana MM; Sturdevant M; Patel G; Huprikar S
Transpl Infect Dis; 2013 Aug; 15(4):E157-63. PubMed ID: 23782431
[TBL] [Abstract][Full Text] [Related]
39. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
[TBL] [Abstract][Full Text] [Related]
40. Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection.
Hyle EP; Lipworth AD; Zaoutis TE; Nachamkin I; Bilker WB; Lautenbach E
Arch Intern Med; 2005 Jun; 165(12):1375-80. PubMed ID: 15983286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
